← Back to Clinical Trials
Recruiting NCT06660043

NCT06660043 Influence of Bodily Practices on the Quality of Life of Women With Endometriosis

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06660043
Status Recruiting
Phase
Sponsor Fondation Hôpital Saint-Joseph
Condition Endometriosis
Study Type INTERVENTIONAL
Enrollment 90 participants
Start Date 2024-03-21
Primary Completion 2025-03-20

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 55 Years
Study Type INTERVENTIONAL
Interventions
physical activityanalgesic physical therapyanalgesic physical therapy AND physical activity

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 90 participants in total. It began in 2024-03-21 with a primary completion date of 2025-03-20.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This research focuses on understanding how physical activity can improve the quality of life for women with endometriosis by enhancing their self-perception, particularly regarding their physical abilities and appearance. The study is based on the idea that improving internal perceptions can lead to better overall well-being for these women. Previous studies, suggest that physical self-perception plays a crucial role in shaping an individual's quality of life. There is also evidence supporting a reciprocal relationship between physical self-concept and participation in physical activity In this context, the research aims to explore how physical activity could positively influence the self-concept of women suffering from endometriosis, which in turn could enhance their quality of life. By focusing on improving both physical abilities and body image through regular exercise, this study seeks to offer insights into potential therapeutic approaches for managing the physical and psychological impacts of endometriosis.

Eligibility Criteria

Inclusion Criteria: * Menstruating women aged 18 to 55; * proven diagnosis of endometriosis (pelvic ultrasound or MRI) * Having endometriosis-related pain of a level higher than 3 on the VAS scale and/or chronic incapacitating symptoms related to endometriosis; * Patient without treatment or with stable endometriosis treatment (pill and/or ATG) who has not undergone treatment during the last 6 months; * Patient affiliated to a health insurance scheme; * French-speaking patient; * Patient having given free, informed and express oral consent. Exclusion Criteria: * Any patient whose endometriosis treatment has been modified for less than 6 months; * Having endometriosis-related pain greater than or equal to 8 on the VAS scale; * Cardiovascular risks related to physical training; * Inability to perform proposed exercises; * Patient under guardianship; * Patient deprived of liberty;

Contact & Investigator

Central Contact

Frederique PERROTTE

✉ fperrotte@ghpsj.fr

📞 +33144127963

Principal Investigator

Frederique PERROTTE

PRINCIPAL INVESTIGATOR

Fondation Hôpital Saint-Joseph

Frequently Asked Questions

Who can join the NCT06660043 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 55 Years, studying Endometriosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06660043 currently recruiting?

Yes, NCT06660043 is actively recruiting participants. Contact the research team at fperrotte@ghpsj.fr for enrollment information.

Where is the NCT06660043 trial being conducted?

This trial is being conducted at Chevry-Cossigny, France, Paris, France.

Who is sponsoring the NCT06660043 clinical trial?

NCT06660043 is sponsored by Fondation Hôpital Saint-Joseph. The principal investigator is Frederique PERROTTE at Fondation Hôpital Saint-Joseph. The trial plans to enroll 90 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology